Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Nice dump by Scotia. 5 cents, here we come.

<< Previous

Bullboard Posts

Next >>

Comment by 90guppyon Jun 10, 2020 6:53pm

107 Views

Post# 31136052

RE:RE:RE:RE:RE:Nice dump by Scotia. 5 cents, here we come.

its actually easy to tell, just look at what they have in their asset and you will see. I know a lot have been concentrating on the pp but take a look at what they have. It is very obvious. The science is there, it has been tested and mind you long before covid, its just that this covid came in the perfect time, no pun intented for those who have suffered. Covid will be the perfect application. Its right in there staring on your faces.